Method: FDA-cleared clinical laboratory assay performed in CLIA-certified, CAP-accredited laboratories. Used to aid clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.

RDW is a measurement of the variability of red blood cell size.

Similar biomarker tests from Superpower

FAQs about Red Cell Dist Width (RDW) Test

Red Cell Distribution Width (RDW) is a standard CBC measurement that shows how much your red blood cells vary in size. It reflects “anisocytosis,” meaning unequal red blood cell size. When the bone marrow is under stress or affected by nutrient deficiency or inflammation, it may release red blood cells of mixed sizes. RDW helps assess the quality and stability of red blood cell production.

RDW can rise before classic anemia markers become obvious, making it useful for flagging early problems in red blood cell production. A high RDW often appears with iron deficiency, vitamin B12 deficiency, or folate deficiency, and it can also reflect inflammatory or metabolic stress. By detecting size variation early, RDW helps identify developing issues that may otherwise be missed on symptoms alone.

High RDW means there’s increased variation in red blood cell size - often a mix of smaller and larger cells circulating together. Common causes include iron deficiency, vitamin B12 or folate deficiency, chronic inflammation, and bone marrow stress. RDW can also rise during recovery from anemia when new red cells enter circulation alongside older cells. Elevated RDW may correlate with cardiovascular stress in some groups.

Low RDW generally indicates your red blood cells are uniform in size, which is typical in healthy individuals. Because RDW measures variation, a low value usually reflects stable, well-regulated red blood cell production and turnover. The context indicates there are no clinically significant concerns tied to low RDW, and it doesn’t meaningfully differ by sex, age, or pregnancy status.

An RDW within range - especially toward the lower end - suggests consistent red blood cell maturation and steady bone marrow output. This pattern supports efficient oxygen delivery and is commonly associated with balanced iron availability, adequate B vitamins, and normal red blood cell lifespan. In practical terms, an “optimal” RDW points to stable red cell production without strong signals of deficiency or chronic inflammatory stress.

Elevated RDW can indicate inefficient oxygen transport due to mixed red blood cell sizes, even when the underlying cause isn’t immediately obvious. This may occur with early iron, B12, or folate deficiency, chronic inflammation, or bone marrow stress. Symptoms like fatigue, weakness, reduced exercise capacity, or shortness of breath may appear as oxygen delivery becomes less efficient across tissues.

RDW is best interpreted alongside a complete blood count (including hemoglobin) and iron studies for diagnostic accuracy. RDW provides the “variation” signal, while hemoglobin and related CBC indices show anemia severity and red cell status. Iron studies help confirm iron deficiency versus other causes of anisocytosis. Using RDW together with these tests offers a fuller picture of nutritional status, red cell production, and inflammatory burden.

Yes. RDW can help detect mixed anemia patterns because a combination of deficiencies or conditions may produce both small and large red blood cells at the same time. This mixed size distribution increases RDW and can suggest overlapping issues such as iron deficiency plus B12/folate insufficiency. Identifying mixed anemia matters because different anemia types require different treatments, and treating only one cause may leave symptoms unresolved.

Chronic inflammation can disrupt red blood cell production and maturation, increasing size variability and raising RDW. In the provided context, elevated RDW correlates with systemic inflammation and oxidative stress and is associated with higher cardiovascular event risk, all-cause mortality, and poorer outcomes in heart failure and diabetes - sometimes independent of anemia. RDW can function as a broad marker of physiologic stress and resilience over time.

RDW can rise during active bleeding, hemolysis, or bone marrow recovery because the bloodstream contains red cells of different ages and sizes. Chronic illness and aging may increase baseline RDW, and certain medications can also elevate values. Pregnancy typically doesn’t change RDW significantly unless anemia develops. These influences are why RDW is most useful when interpreted in clinical context with CBC and iron studies.